Quimatryx’s compound has demonstrated high efficacy in solid tumours, such as pancreatic cancer, and blood tumours, such as mantle cell lymphoma. El compuesto de Quimatryx ha demostrado una alta eficacia en tumores sólidos, como cáncer de páncreas, y tumores sanguíneos, como el linfoma de células del manto. The basque-based company Quimatryx, which is developing a…
